Published in
Elsevier, Pharmacology and Therapeutics, (239), p. 108277, 2022
DOI: 10.1016/j.pharmthera.2022.108277
Links
Tools
Incretin-based drugs as potential therapy for neurodegenerative diseases: current status and perspectives
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 